The Effect of Vitamin a Supplementation on Disease Progression, Cytokine Levels and Gene Expression in Multiple Sclerotic Patients: Study Protocol For a Randomized Controlled Trial
Multiple Sclerosis (MS) is a chronic inflammatory disease that leads to degeneration of the brain and spinal tissue. Imbalances of CD4+ T cells including Thelper1 (Th1)/Thelper2 (Th2) and Thelper17 (Th17)/Tregulatory (Treg), their secreted cytokines and gene expressions, are important aspects of in immunopathogenesis of MS. Vitamin A and its metabolites can regulate the immune system and appears to be effective in preventing progression of the autoimmune disease such as MS. Disease progression was evaluated By Magnetic Resonance Imaging (MRI), Expanded Disability States Scale (EDSS) and Multiple Sclerosis Functional Composite (MSFC) tests. Cytokine levels were measured using ELISA kits and gene expression was quantified by Real time PCR (RT-PCR) system. According to the difference between the epidemiological and clinical data on the relationship between vitamin A and immune system regulation, this study of the first time assesses Immune function as well as gene expression and progression of the disease following administration of vitamin A supplement.
Chen SJ, Wang YL, Fan HC, et al. Current Status of the Immunomodulation and Immunomediated Therapeutic Strategies for Multiple Sclerosis. Clin Dev Immunol 2012;2012:970789.
Fox RJ, Beall E, Bhattacharyya P, et al. Advanced MRI in Multiple Sclerosis. Current Status and Future Challenges. Neurol Clin 2011;29(2):357-80.
Frohman EM, Racke MK, Raine CS. Multiple sclerosis -- the plaque and its pathogenesis. N Engl J Med 2006;354(9):942-55.
Comabella M, Khoury SJ. Immunopathogenesis of multiple sclerosis. Clin Immunol 2012;142(1):2-8.
Jadidi- Niaragh F, Mirshafiey A. Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis. Scand J Immunol 2011;74(1):1-13.
Nowak EC, Weaver CT, Turner H, et al. IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med 2009;206(8):1653-60.
Serres S, Anthony DC, Jiang Y, et al. Systemic Inflammatory Response eactivates Immune-Mediated Lesions in Rat Brain. J Neurosci 2009;29(15):4820-8.
Boppana S, Huang H, Ito K, et al. Immunologic Aspects of Multiple Sclerosis. Mt Sinai J Med 2011;78(2):207-20.
Adorini L. Immunotherapeutic approaches in multiple sclerosis. J Neurol Sci 2004;223(1):13-24.
Prat A, Biernacki K, Lavoie JF, et al. Migration of multiple sclerosis lymphocytes through brain endothelium. Arch Neurol 2002;59(3):391-7.
Xiao S, Jin H, Korn T, et al. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 2008;181(4):2277-84.
Mucida D, Park Y, Kim G,et al, Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007;317(5835):256-60.
Lovett-Racke AE, Racke MK. Retinoic acid promotes the development of Th2-like human myelin basic proteinreactive T cells. Cell Immunol 2002;215(1):54-60.
Ziouzenkova O, Plutzky J. Retinoid metabolism and nuclear receptor responses:New insightsinto coordinated regulation of the PPAR–RXR complex. FEBS Lett 2008;582(1):32-8.
Parés X, Farrés J, Kedishvili N, et al. Medium-chain and short-chain dehydrogenases/reductases in retinoid metabolism. Cell Mol Life Sci 2008;65(24):3936-49.
Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 2004;23(1):S208-19
Jenkinson M, Bannister P, Brady M, et al. Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images. Neuro Image 2002;17(2):825-41.
Smith SM, Brady JM. SUSAN- A New Approach to Low Level Image Processing. Int J Comput Vis 1997;23(1):45-78.
Smith SM, Zhang Y, Jenkinson M, et al. Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis. NeuroImage 2002;17(1):479-89.
Bach MK, Brashler JR. Isolation of subpopulations of lymphocytic cells by the use of isotonically balanced solutions of Ficoll. I. Development of methods and demonstration of the existence of a large but finite number of subpopulations. Exp Cell Res 1970;61(2):387-96.
Mottaghi A, Salehi E, Sezavar H, et al. The in vitro Effect of Oxidized LDL and PHA on Proliferation and Gene Expression of Regulatory T Cells in Patients withAtherosclerosis. Iran J Allergy Asthma Immunol 2012;11(3):217-23.
Zago LB, Dupraz H, Sarchi MI, et al. The molar ratio of retinol-binding protein to transthyretin in the assessment of vitamin A status in adults. Proposal of a cut-off point. ClinChem Lab Med 2002;40(12):1301-7.
Loma I, Heyman R. Multiple Sclerosis:Pathogenesis and Treatment. Curr Neuropharmacol 2011;9(3):409-16.
Jäger A, Dardalhon V, Sobel RA, et al. Th1, Th17 and Th9 effector cells induce experimental autoimmuneencephalomyelitis with different pathological phenotypes.J Immunol 2009;183(11):7169-77.
Pappas DJ, Oksenberg JR. Multiple sclerosis pharmacogenomics:maximizing efficacy of therapy.Neurology 2010;74(1):S62-9.
Hall JA, Cannons JL, Grainger JR, et al. Essential Role for Retinoic Acid in the Promotion of CD4(+) T Cell EffectorResponses via Retinoic Acid Receptor Alpha. Immunity 2011;34(3):435-47.
Cassani B, Villablanca EJ, De Calisto J, et al. Vitamin A and immune regulation: Role of retinoic acid in gutassociated dendritic cell education, immune protection and tolerance. Mol Aspects Med 2012;33(1):63-76.
Jafarirad S, Siassi F, Harirchian MH, et al. The Effect of Vitamin A Supplementation on Stimulated T-cell Proliferation with Myelin Oligodendrocyte Glycoprotein in Patients with Multiple Sclerosis. J Neurosci Rural Pract 2012;3(3):294-8.
Pino-Lagos K, Benson MJ, Noelle RJ. Retinoic Acid in the Immune System. Ann N Y Acad Sci 2008;1143(21):170-87.
|Issue||Vol 52, No 2 (2014)|
|Multiple sclerosis Vitamin A Magnetic resonance imaging Cytokine Gene expression|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|